ATE236620T1 - Zusammensetzungen mit langsamer freigabe enthaltend eine zinkverbindung und vitamin c- derivate - Google Patents

Zusammensetzungen mit langsamer freigabe enthaltend eine zinkverbindung und vitamin c- derivate

Info

Publication number
ATE236620T1
ATE236620T1 AT99307047T AT99307047T ATE236620T1 AT E236620 T1 ATE236620 T1 AT E236620T1 AT 99307047 T AT99307047 T AT 99307047T AT 99307047 T AT99307047 T AT 99307047T AT E236620 T1 ATE236620 T1 AT E236620T1
Authority
AT
Austria
Prior art keywords
zinc
zinc compound
vitamin
slow release
derivatives
Prior art date
Application number
AT99307047T
Other languages
English (en)
Inventor
John C Godfrey
Original Assignee
John C Godfrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John C Godfrey filed Critical John C Godfrey
Application granted granted Critical
Publication of ATE236620T1 publication Critical patent/ATE236620T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99307047T 1998-09-03 1999-09-03 Zusammensetzungen mit langsamer freigabe enthaltend eine zinkverbindung und vitamin c- derivate ATE236620T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/145,975 US6316008B1 (en) 1998-09-03 1998-09-03 Combination of zinc ions and vitamin C and method of making

Publications (1)

Publication Number Publication Date
ATE236620T1 true ATE236620T1 (de) 2003-04-15

Family

ID=22515388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99307047T ATE236620T1 (de) 1998-09-03 1999-09-03 Zusammensetzungen mit langsamer freigabe enthaltend eine zinkverbindung und vitamin c- derivate

Country Status (10)

Country Link
US (1) US6316008B1 (de)
EP (1) EP0987021B1 (de)
JP (1) JP3875811B2 (de)
AT (1) ATE236620T1 (de)
AU (1) AU755724B2 (de)
BR (1) BR9904036A (de)
CA (1) CA2281054C (de)
DE (1) DE69906651T2 (de)
IL (1) IL131541A0 (de)
ZA (1) ZA994998B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2386423C (en) 1999-10-04 2009-07-21 John Carter Pharmaceutical compositions containing copper, salicylic acid and vitamines c
GB2374008B (en) * 2001-04-04 2005-03-16 John Carter Pharmaceutical compositions comprising copper and zinc
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
US20070092552A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Chewable lozenge cold remedy composition and method for making same
JP4929628B2 (ja) * 2004-07-08 2012-05-09 大正製薬株式会社 亜鉛含有内服液剤
US7582418B2 (en) * 2004-11-03 2009-09-01 Albion Laboratories, Inc. Antimicrobial chelates
US20090081294A1 (en) * 2007-09-26 2009-03-26 Gin Jerry B Sustained release dosage form for lubricating an oral cavity
US20090081291A1 (en) * 2007-09-26 2009-03-26 Gin Jerry B Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User
MX2011004678A (es) 2008-11-04 2011-10-11 Vymedic Llc Formulaciones complementarias antivirales.
US8247435B2 (en) * 2009-02-19 2012-08-21 Thornthwaite Jerry T Formulations for treating human and animal diseases
EP2283805A1 (de) 2009-07-28 2011-02-16 Sirvis BV Zusammensetzungen bestehend aus Zink, welches eine Verbindung in der hydrophoben Phase enthält
US20110028412A1 (en) * 2009-08-03 2011-02-03 Cappellos, Inc. Herbal enhanced analgesic formulations
WO2017123103A1 (en) * 2016-01-15 2017-07-20 Dee, Kennie U. Stable and palatable composition of vitamin c and zinc lozenge tablets
CN107913294A (zh) * 2017-10-31 2018-04-17 安徽鸿泰食品有限公司 一种孕妇补锌营养液
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
EP4069671A4 (de) * 2020-07-17 2024-03-06 Jost Chemical Co. Zweiwertiges metallascorbat-glycinat-kosalz
WO2025038636A1 (en) 2023-08-14 2025-02-20 Vymedic, Inc. Antiviral supplement formulations for herpesvirus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63141921A (ja) 1986-12-04 1988-06-14 Kao Corp 口腔用組成物
AU646840B2 (en) 1990-02-05 1994-03-10 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
US5626883A (en) 1994-04-15 1997-05-06 Metagenics, Inc. Ascorbic acid compositions providing enhanced human immune system activity
US5897891A (en) * 1996-11-18 1999-04-27 Godfrey; John C. Flavorful zinc compositions for oral use incorporating copper
US5759559A (en) 1997-05-05 1998-06-02 Fitzjarrell; Edwin A. Method and composition for treating acne

Also Published As

Publication number Publication date
DE69906651D1 (de) 2003-05-15
BR9904036A (pt) 2000-09-26
JP3875811B2 (ja) 2007-01-31
DE69906651T2 (de) 2003-12-18
EP0987021A1 (de) 2000-03-22
EP0987021B1 (de) 2003-04-09
IL131541A0 (en) 2001-01-28
JP2000086522A (ja) 2000-03-28
ZA994998B (en) 2000-02-18
AU4734999A (en) 2000-03-16
CA2281054A1 (en) 2000-03-03
AU755724B2 (en) 2002-12-19
CA2281054C (en) 2002-11-19
US6316008B1 (en) 2001-11-13

Similar Documents

Publication Publication Date Title
DE69906651D1 (de) Zusammensetzungen mit langsamer Freigabe enthaltend eine Zinkverbindung und Vitamin C-Derivate
BR9705484A (pt) Composições de zinco com sabor para uso oral incorporando cobre
IL100770A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
ATE190834T1 (de) Orale zusammensetzung gegen zahnbelag
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
GR3033191T3 (en) Dosage form comprising alpha-lipoic acid or solid salts thereof with improved bioavailability
ATE251853T1 (de) Flüssige, orale zusammensetzung, welche eine kalziumverbindung und eine säure enthält
ATE269069T1 (de) Orale zubereitung enthaltend einen biguanid und eine organische säure
SE8902288D0 (sv) Farmaceutisk komposition
AU6314790A (en) Oral pharmaceutical composition for acid sensitive proteinaceous agents
IT1217445B (it) Composizione farmaceutiche orosolubili contenti acetilcisteina
HUP0301080A3 (en) Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives, process for their preparation and pharmaceutical compositions containing them
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ITMI911880A1 (it) Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
AU2615795A (en) Compounds and compositions for administration via oral inhalation or insufflation
IL98576A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
WO2001024803A3 (en) Pharmaceutical compositions containing copper, salicylic acid and vitamines c
HU9600758D0 (en) Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
DE60029979D1 (de) LIPOSOMZUSAMMENSETZUNG VON 6,9-BIS-i(2-AMINOETHYL)-AMINOöBENZOiGöISOQUINOLIN-5,10-DIONE-DIMALEAT
IL117045A (en) Substituted N-(2,3-dihydro-1,4-dioxino Ú2,3-b¾pyridine-2-yl) alkanediamine derivatives their preparation and pharmaceutical compositions containing them
GR3015777T3 (en) Substituted amino acid amide derivatives, their preparation and use.
HUP9902955A3 (en) Water-soluble 20 (s)-camptothecin derivatives substituted at position-5, process for their preparation, their use and pharmaceutical compositions containing the same compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties